drugset / Trial / NCT02073461

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

NCT02073461 ↗

Phase 2 Completed 236 enrolled Galderma R&D
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to assess the efficacy and safety of two concentrations of CD1579 (2.5% and 5%) versus vehicle in the treatment of acne vulgaris in the Japanese patients.

Timeline

Start
2014-03
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject CD1579 Unknown 2.5 % —
Subject CD1579 Unknown 5 % —

Indications